KRAS and neoplasm: Contradictory evidence exists to show inhibition of KRAS leading to tumor regression [55,56,57,58], and KRAS-mutant cell lines exist whose growth and tumorigenicity do not depend on oncogenic KRAS [59,60,61], on the other hand.